Live birth patterns among human immunodeficiency virus-infected women before and after the availability of highly active antiretroviral therapy

Anjali Sharma, Joseph G. Feldman, Elizabeth T. Golub, Julie Schmidt, Sylvia Silver, Esther Robison, Howard Minkoff

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Abstract

Objective: The objective of the study was to investigate the relationship between human immunodeficiency virus (HIV) infection and childbearing before and after the availability of highly active antiretroviral therapy (HAART). Methods: Enrollment in the Women's Interagency HIV study took place in 1994-1995 (pre-HAART era) and again in 2001-2002 (HAART era). Live birth rates prior to enrollment were compared between treatment era cohorts for HIV-infected and HIV-uninfected women aged 15-44 years using Poisson regression. For HIV-infected women, we included live births between HIV diagnosis date and study entry; the HAART era cohort included only women diagnosed with HIV in 1996 and afterward. Results: Among HIV-infected women, the HAART era live birth rate was 150% higher than in the pre-HAART era (P = .001) vs a 5% increase among HIV-uninfected women. The rate of increase in live birth rate was higher for women ≥35 years old (vs younger than 25 years, P = .02), and with more than a high school education (vs. less than high school, P = .05). Conclusion: The availability of effective therapeutic interventions has had a profound impact on child-bearing among HIV-infected women.

Original languageEnglish (US)
Pages (from-to)541.e1-541.e6
JournalAmerican journal of obstetrics and gynecology
Volume196
Issue number6
DOIs
StatePublished - Jun 2007

Keywords

  • birth rate
  • highly active antiretroviral therapy
  • human immunodeficiency virus
  • reproductive decision making
  • women

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Live birth patterns among human immunodeficiency virus-infected women before and after the availability of highly active antiretroviral therapy'. Together they form a unique fingerprint.

Cite this